infection is characterized by viremia, rapid decrease in CD4 + T-cell counts and flu-like 11 symptoms. In the asymptomatic stage, viral load is generally low and the CD4 + T-cell 12 decline moderate. Finally, in the AIDS stage, viral loads increase, the CD4 + T cell count 13 continues to decrease and opportunistic diseases develop due to a dysfunctional immune 14 system. 15
Two genetically related but distinct human lentiviruses, HIV-1 and HIV-2, have been 16 described 1,2 . Whereas HIV-1 is pandemic, HIV-2 is mainly confined to West Africa. Both 17 viruses share similar transmission routes, cellular targets and AIDS causatives. However, 18
an HIV-2 infection is characterized by a much longer asymptomatic stage, lower plasma 19 viral load, slower decline in CD4 + T-cell counts, and lower mortality rate [3] [4] [5] [6] . 20
HIV enters target cells via interactions with CD4 and a co-receptor, usually one of the 21 chemokine receptors CCR5 or CXCR4. Whereas CCR5-using strains usually are present 22 throughout the complete disease course, CXCR4-using strains generally emerge in late-23 5 have shown that the development of CXCR4-using strains is favoured by a weak immune 1 system and depends on the level of specific antiviral responses against these strains 22 . It is 2 possible that HIV-2 could alter the expression of cellular factors in trans, and thereby affect 3 the HIV-1 co-receptor tropism in dual-infected individuals. In vitro studies have shown that 4 HIV-2 infection generates higher levels of β-chemokines (the natural ligands of CCR5) in 5 peripheral blood mononuclear cells than HIV-1 infection, and that this can inhibit HIV-1 6 infection and replication 23, 24 . It was hypothesised that such up-regulation could favor HIV-1 7 to switch from CCR5 to CXCR4-use in dual-infected individuals at a higher rate than in 8 single-infected individuals. In the current, we found the opposite, suggesting that the 9 potential in vivo effect of increased β-chemokine levels does not result in higher levels of 10 HIV-1 CXCR4-tropism in dual-infected individuals. 11
In summary, we show a lower prevalence of HIV-1 CXCR4-using tropism in dual 12 than in single-infected individuals. Our results suggest that the "diversity threshold theory" 13 is a plausible model for HIV-1 evolution also in late-stage disease. Alterations in co-14 receptor tropism could be an important correlate of the natural inhibition against HIV-1 15 disease progression by contemporaneous HIV-2 infection. Tables   1   Table 1 . Clinical data of the single and dual-infected individuals. 2 a n = number of individuals.
b Mean CD4 + T-cell count measured in cell/mm 3 . c Differences 3 between the groups were tested statistically using the Student's T-test. 
Supplementary Methods 1

Sample set 2
The samples used in this study were selected from a sample set of 52 plasma samples from 52 3 HIV-1 infected individuals and was selected from a cohort of police officers from Guinea-4 Bissau, West Africa, based on sample availability and disease status. The cohort has been 5 described in detail elsewhere 1-3 . In addition, five plasma samples from individuals with a 6 recorded HIV-1 and HIV-2 dual-infection were included from a case-control cohort from 7
Bissau, Guinea-Bissau 4 . Forty-seven of the samples were successfully amplified (29 from 8 single-infected individuals and 18 from dual-infected individuals). Only individuals with 9 subtype A-like HIV-1 strains could be analyzed in the recombinant phenotypic assay as 10 described 5 . Two individuals were infected with HIV-1 of subtype C and CRF06_cpx, 11 respectively, and were not subjected to further analyses (Supplementary Table 1 subjected for further analysis. Subtype determination and removal of putative recombinants 24 were performed as previously described. A final dataset of 370 HIV-1 env V1-V3 25 sequences (mean 8.22 clones/individual) were aligned using PRANK+F with a neighbor 1 joining tree, constructed in MEGA4, as guide tree 9,10 . The PRANK+F algorithm aligns 2 sequences using phylogenetic information and has been shown to align sequences in an 3 evolutionarily sound way. The alignment was manually edited and codon-stripped, resulting 4 in a final sequence length of 654 nucleotides. Maximum-likelihood (ML) phylogenies, based 5 on 1000 bootstrap alignments, were constructed in Garli 0.951 6 (www.bio.utexas.edu/faculty/antisense/garli/Garli.html) 11 . This method efficiently maximizes 7 the tree loge likelihood by using a genetic algorithm implementing the nearest neighbor 8 interchange (NNI) and the subtree pruning regrafting (SPR) algorithms on a random starting 9 tree to simultaneously find and optimize the topology and branch lengths 11, 12 . The diversity 10 was calculated by averaging pairwise tree distances between patient-specific sequences. This 11 was done in all of the generated trees, yielding 1,000 estimates for each individual. The 12 median value for each individual was used in the analysis. 13
14
Determination of coreceptor tropism 15
Coreceptor tropism was determined according to a previously described protocol 5 . Briefly, 16 human kidney embryonic 293T cells and human glioma U87.CD4 cells, stably expressing 17 CD4 and one of the chemokine receptors (CCR5 or CXCR4) were employed as indicator 18 cells 13, 14 . Chimeric viruses with patient-specific V1-V3 regions were generated based on the 19 protocol from the Tropism Recombinant Test (TRT) with minor modifications 15, 16 . Amplified 20 V1-V3 fragments from each plasma sample and 43XCΔV, a NheI-linearized vector 21 containing a full-length pNL4-3 genome with the V1-V3 region deleted, were transfected into 22 293T cells using the calcium phosphate precipitation method. Chimeric viruses were 23 harvested and stored at -80˚C. For infection, chimeric viruses were added in duplicate wells 24 containing semi-confluent U87.CD4 cells. Cultures were analyzed at day one, seven and nine 1 for p24 antigen production by ELISA (Biomérieux, Boxtel, The Netherlands). 
